chen yen yang - Search Results

Year	Number of Results
2004	1
2005	1
2006	1
2008	1
2009	1
2010	1
2011	6
2012	4
2013	2
2014	11
2015	9
2016	5
2017	4
2018	7
2019	10
2020	10
2021	11
2022	12
2023	10
2024	2

1

Short-term and long-term outcomes of on-pump beating-heart coronary artery bypass surgery in dialysis and non-dialysis patients: a retrospective study in a single center.

Lin CH, Chen YY, Yen YT, Kao PH, Chua CH, Chao HH, Lu MJ. Lin CH, et al. Among authors: chen yy. J Cardiothorac Surg. 2024 Apr 30;19(1):268. doi: 10.1186/s13019-024-02662-6. J Cardiothorac Surg. 2024. PMID: 38689317 Free PMC article.

2

Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer.

Tang CY, Yang SH, Li CP, Su YY, Chiu SC, Bai LY, Shan YS, Chen LT, Chuang SC, Chan DC, Yen CJ, Peng CM, Chiu TJ, Chen YY, Chen JS, Chiang NJ, Chou WC. Tang CY, et al. Among authors: chen yy. Pancreatology. 2024 Mar 25:S1424-3903(24)00076-0. doi: 10.1016/j.pan.2024.03.014. Online ahead of print. Pancreatology. 2024. PMID: 38565467

3

Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation.

Su YY, Chiang NJ, Chiu TJ, Huang CJ, Hsu SJ, Lin HC, Yang SH, Yang Y, Chou WC, Chen YY, Bai LY, Li CP, Chen JS. Su YY, et al. Among authors: chen yy. Biomed J. 2023 Dec 31:100696. doi: 10.1016/j.bj.2023.100696. Online ahead of print. Biomed J. 2023. PMID: 38169173 Free article. Review.

4

Proton beam therapy for downstaging hepatocellular carcinoma with lobar portal vein tumor thrombosis to living donor liver transplantation.

Chen CL, Dungca LBP, Yong CC, Chen IC, Cheng YF, Cheng JY, Chen YY. Chen CL, et al. Among authors: chen yy. Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):966-974. doi: 10.21037/hbsn-23-410. Epub 2023 Nov 15. Hepatobiliary Surg Nutr. 2023. PMID: 38115927 Free PMC article. No abstract available.

5

Combined Serum ALBUMIN with Neutrophil-to-Lymphocyte Ratio Predicts the Prognosis of Biliary Tract Cancer after Curative Resection.

Chiu TJ, Liu YW, Yong CC, Yin SM, Yeh CH, Chen YY. Chiu TJ, et al. Among authors: chen yy. Cancers (Basel). 2023 Nov 19;15(22):5474. doi: 10.3390/cancers15225474. Cancers (Basel). 2023. PMID: 38001734 Free PMC article.

6

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.

Rha SY, Oh DY, Yañez P, Bai Y, Ryu MH, Lee J, Rivera F, Alves GV, Garrido M, Shiu KK, Fernández MG, Li J, Lowery MA, Çil T, Cruz FM, Qin S, Luo S, Pan H, Wainberg ZA, Yin L, Bordia S, Bhagia P, Wyrwicz LS; KEYNOTE-859 investigators. Rha SY, et al. Lancet Oncol. 2023 Nov;24(11):1181-1195. doi: 10.1016/S1470-2045(23)00515-6. Epub 2023 Oct 21. Lancet Oncol. 2023. PMID: 37875143 Clinical Trial.

7

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma.

Chen YH, Tsai CH, Chen YY, Wang CC, Wang JH, Hung CH, Kuo YH. Chen YH, et al. Among authors: chen yy. BMC Cancer. 2023 Aug 29;23(1):810. doi: 10.1186/s12885-023-11298-z. BMC Cancer. 2023. PMID: 37644388 Free PMC article.

8

The Efficacy and Safety of Ramucirumab in Heavily Pretreated Advanced Hepatocellular Carcinoma.

Chen YH, Tsai CH, Chen YY, Wang CC, Wang JH, Hung CH, Kuo YH. Chen YH, et al. Among authors: chen yy. Anticancer Res. 2023 Jul;43(7):3203-3212. doi: 10.21873/anticanres.16494. Anticancer Res. 2023. PMID: 37351980

9

Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients.

Chen YH, Chen YY, Wang JH, Hung CH. Chen YH, et al. Among authors: chen yy. Anticancer Res. 2023 Mar;43(3):1377-1384. doi: 10.21873/anticanres.16286. Anticancer Res. 2023. PMID: 36854513

10

Combination of Lenvatinib and Proton Beam Therapy in the Management of Patients With Advanced Hepatocellular Carcinoma.

Cheng JY, Huang BS, Chen YY, Wang CC, Chen YH. Cheng JY, et al. Among authors: chen yy. Anticancer Res. 2023 Mar;43(3):1361-1371. doi: 10.21873/anticanres.16284. Anticancer Res. 2023. PMID: 36854503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

99 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year